Sentence examples for development of infectivity from inspiring English sources

In the Introduction to our article, we supported a statement about the loss of infectivity of sporozoites following in vitro incubation with an inappropriate citation: Vanderberg, J.P. (1975) Development of infectivity by the Plasmodium berghei sporozoite.

Development of a robust, infectivity-based high throughput screening process for identifying thermostable vaccine formulations offers significant promise for vaccine development across a wide variety of LAV products.

The study of the volume of schizonts and merosome buds could be criteria to analyze the development and infectivity of EEFs. Figure 3: Sporozoite motility in the liver (also see Supplementary Video 1 online).

Owing to an interest in vaccine development, the infectivity of B. pertussis has been evaluated in many animal models, but only three studies in the mouse model met the data selection criteria.

Taken together, these results indicate that specific knock-out the VdGARP1 gene indeed results in severe inhibition of melanized microsclerotial development and lost infectivity of V592.

The infectivity and development of P. berghei [PyCS] has been shown previously to be similar to those of the parent P. berghei both in the mosquito and in the mouse [13].

Assuming the life cycles of Ich and its infectivity are controlled by gene products, then it would be of great interest to learn what genes are involved in the loss of infectivity, and in the slowing down of its development.

We reasoned that low titers of infectious virus might be below the level of detection of the plaque assay and decided to monitor infectivity by the development of CPE in HeLa cells.

Understanding of the relevance of prolonged fecal norovirus excretion must await the development of sensitive methods to measure virus infectivity.

In the present study, our goal was to measure the rate of infectivity of Pv spz in HepG2-A16 cells and rate of development of invaded Pv spz into hepatocyte stages.

The fact that VACV has the capacity to hold at least 25 kb of heterologous DNA while retaining infectivity also enables the development of multi-pathogen, multi-epitope polyvalent vaccines.